Other languages Shuttle Pharmaceuticals Holdings, Inc.

Equities

SHPH

US8256932034

Delayed Nasdaq Other stock markets 12:19:19 05/06/2024 am IST			5-day change	1st Jan Change
0.5186 ^USD	-3.61%		+16.85%	+13.98%

13/05	Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
21/03	Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma	08/01
Shuttle Pharmaceuticals Holdings, Inc. Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma	11/12
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma	25/23/25
Shuttle Pharmaceuticals Holdings, Inc. Expands Patent Coverage on HDAC Inhibitor Platform	11/23/11
Top Premarket Gainers	08/23/08
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15
Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient for Use in Clinical Trial	03/23/03
Top Premarket Gainers	26/23/26
Shuttle Pharmaceuticals Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/23/26
Shuttle Pharmaceuticals, Georgetown University Sign Research Deal to Evaluate Anti-Tumor Candidates	23/23/23
Shuttle Pharmaceuticals Holdings, Inc. Auditor Raises 'Going Concern' Doubt	15/23/15
Shuttle Pharmaceuticals Signs Ropidoxuridine Manufacturing Deal With University of Iowa Pharmaceuticals	09/23/09
Shuttle Pharmaceuticals Expands Laboratory Space to Advance Drug Development Pipeline and Diagnostic Capabilities	23/23/23
Sector Update: Health Care Stocks Steady Friday Afternoon While Other Sectors Rebound	14/23/14
Sector Update: Health Care Standing Firm as Broader Markets Catch Up	14/23/14
Sector Update: Health Care	14/23/14
Sector Update: Health Care Stocks Mixed Pre-Bell Friday	13/23/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Shuttle Pharmaceuticals Holdings, Inc.

Equities

SHPH

US8256932034

Other languages

Filters